Mphasis stock gets a Social Security Scotland contract extension

Published on 10/07/2026 at 02:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mphasis signed a GBP 35.4 million agreement on October 6, 2026, supporting a platform used by more than 2 million people. Q1 FY27 revenue rose 17.5 percent year over year.

Mphasis, INE356A01018, Illustration mit AI erstellt.

Mphasis stock (ISIN INE356A01018) was last at INR 2,298 on the NSE on October 6, 2026, after the company extended its Social Security Scotland partnership through a GBP 35.4 million agreement. The contract covers maintenance of a benefits platform used by more than 2 million people, according to FT.com on October 6, 2026.

Contract expands public sector reach

The agreement keeps Mphasis responsible for managing and maintaining Social Security Scotland's core benefits case management platform. The system supports applications, eligibility decisions and payments, giving the deal an operational continuity angle rather than a new-platform rollout.

FT.com reported that the arrangement is designed to support stable and resilient service delivery. For Mphasis, the public-sector engagement adds visibility to a business already focused on banking, financial services, insurance and digital transformation.

Q1 growth meets margin pressure

Mphasis reported Q1 FY27 revenue of INR 43.84 billion, up 17.5 percent year over year, while net profit rose 10.82 percent to INR 4.90 billion, according to Sahi. Sequential revenue growth was 3.3 percent from Q4 FY26, but operating EBIT margin declined 60 basis points to 14.78 percent.

The next test is the September quarter. NDTV Profit reported that Mphasis will announce Q2 FY27 results on November 5, 2026, followed by an earnings call on November 6. Revenue growth, deal wins and margin recovery will determine whether the contract momentum converts into broader operating progress.

Brokerage target sits above NSE price

Nexuswild reported that HDFC Securities assigned Mphasis an Add rating and a target price of INR 2,840 in its Q2 FY27 preview dated October 1, 2026. That target is 23.6 percent above the October 6 price of INR 2,298, making the upcoming results a direct test of the growth assumptions behind the brokerage view.

Mphasis stock was 22.8 percent below its 52-week high of INR 2,975 and 14.2 percent above its 52-week low of INR 2,013 on October 6, 2026. Its market capitalization stood at INR 438.5 billion, while volume reached 286,666 shares.